author-photo

Wouter Haazen

Thomas Jefferson University

5

Papers

194

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies

2017 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (8)
Restarting Dabigatran Etexilate 24 h After Reversal With Idarucizumab and Redosing Idarucizumab in Healthy Volunteers

2016 Journal of the American College of Cardiology
Show All
- Source
- Cite
- Save
Citations (34)
Idarucizumab, a Specific Antidote for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran Induced Anticoagulation in Elderly and Renally Impaired Subjects

2014 Blood
Show All
- Source
- Cite
- Save
Citations (55)